Skip to content

Glomerulonephritis, Lupus Nephritis and Vasculitis Clinical Study Group

The kidney can be damaged by activation of the immune system which then attacks healthy body tissue. This results in antibodies and other immune elements targeting the kidney and causing inflammation, 'nephritis'. The filters of the kidney, the 'glomeruli', are typically affected hence the term 'glomerulonephritis'.

There are several patterns of glomerulonephritis with differing risks of destroying the kidney which results in end stage renal disease. Treatment strategies are usually aimed at reducing inflammation and controlling the abnormal immune activation.

Who we are

We are a group of health professionals with an interest in glomerular disease dedicated to clinical research with national and international collaboration.

Our group is chaired by Dr Rachel Jones, Consultant in Nephrology and Vasculitis at Addenbrooke’s Hospital, Cambridge, and Professor Jon Barratt, Professor of Renal Medicine at the University of Leicester.

Membership is informal and inclusive, with a current mailing list consisting of representation from 47 renal units, membership from Kidney Research UK and also patients. Because of the diversity of and rarity of glomerular diseases, research themes have evolved around specific glomerular disease areas linking into associated RaDaR and UK and Ireland Vasculitis Rare Disease (UKIVAS) groups. Additionally we are delighted to share that we have now established a new strong educational component of national educational meetings led by Dr Allyson Egan, Trinity Health Kidney Centre, Tallaght University Hospital Dublin.

All consultants, allied healthcare professionals and anyone with an interest in glomerular disease are welcome!

Dr Rachel Jones
Dr Rachel Jones
Jon Barratt
Professor Jon Barratt

Our aims:

  • Identifying areas of unmet need for research activity.
  • Developing new studies; registry, biomarker and clinical trials.
  • Acting as a portal to promote engagement in glomerulonephritis, vasculitis and lupus studies.
  • Communicating with patient groups.
  • Developing collaborations with industry and academic partners.
  • Providing expert review for project proposals.
  • Supporting funding applications.
  • Providing an education and training programme.


C3 Glomerulopathy

IgA Nephropathy

Lupus Nephritis

Membranous Nephropathy

Minimal Change Disease and Focal Segmental Glomerulo Sclerosis

Got a question? Get in touch.

For more information and to find out about getting involved as a patient or researcher, contact:

Scroll To Top